RT Journal Article
SR Electronic
A1 Buckley, Rita
T1 Apixaban Superior to Warfarin in Patients with Atrial Fibrillation as well as Prior Stroke or TIA
JF MD Conference Express
YR 2012
FD SAGE Publications
VO 12
IS 1
SP 10
OP 11
DO 10.1177/155989771201002
UL http://mdc.sagepub.com/content/12/1/10.abstract
AB The recent Apixaban Compared with Warfarin in Patients with Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack trial [Granger CB et al. N Engl J Med 2011; ARISTOTLE; NCT00412984] found apixaban to be superior to warfarin for stroke prevention in a wide range of atrial fibrillation (AF) patients, with significantly lower bleeding risk and lower risk of all-cause mortality [Littrell R, Flaker G. Expert Rev Cardiovasc Ther 2012]. This article results of a comparison of apixaban with warfarin in patients with AF and prior stroke or transient ischemic attack.